DIFFUSION PHARMACEUTICALS
Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most. Diffusion’s lead product candidate, TSC, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine’s most intractable and difficult-to-treat conditions. In addition to TSC, Diffusion’s product candidate DFN-529, a novel PI3K/Akt/mTOR pathway inhibitor, is in early-stage development.
DIFFUSION PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2001-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.diffusionpharma.com
Total Employee:
11+
Status:
Active
Contact:
4342200722
Email Addresses:
[email protected]
Total Funding:
119.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache Mobile Non Scaleable Content
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
GIRx
GIRx is developing small molecule agents to treat diabetes, obesity and other metabolic conditions.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-12-28 | Stratus Media Group | Stratus Media Group acquired by Diffusion Pharmaceuticals | N/A |
Investors List
Jaffray Woodriff
Jaffray Woodriff investment in Convertible Note - Diffusion Pharmaceuticals
Jaffray Woodriff
Jaffray Woodriff investment in Debt Financing - Diffusion Pharmaceuticals
Jaffray Woodriff
Jaffray Woodriff investment in Debt Financing - Diffusion Pharmaceuticals
Office of Naval Research
Office of Naval Research investment in Grant - Diffusion Pharmaceuticals
U.S. Food and Drug Administration
U.S. Food and Drug Administration investment in Private Equity Round - Diffusion Pharmaceuticals
Third Security
Third Security investment in Grant - Diffusion Pharmaceuticals
Office of Naval Research
Office of Naval Research investment in Grant - Diffusion Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-18 | Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer |
Official Site Inspections
http://www.diffusionpharma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
